IL1B and colorectal carcinoma: Furthermore, selective small molecule inhibition of PKCι with CRT0066854 significantly disrupted IL-1β-inducible activation of NF-ĸB luciferase activity with increasing μM concentrations of inhibitor compared to the vehicle control CRC cells (Figure 7C).